While it has been suggested that T-cell exhaustion signature concurs with a lower risk of relapse and symptom recurrence47, depletion of PD-1+ T cells in established type I diabetes (T1D) and experimental autoimmune encephalomyelitis (EAE) models favorably influences the clinical outcome48. The gene discussed is PDCD1; the disease is type 1 diabetes mellitus.